Feedback / Questions
AFNT-212 - Affini-T Therap
https://www.businesswire.com/news/home/20230509005408/en/Affini-T-Therapeutics-to-Present-Novel-CRISPR-Gene-Editing-Data-from-its-Oncogenic-Driver-Program-Targeting-KRAS-at-the-American-Society-of-Gene-and-Cell-Therapy-26th-Annual-Meeting
May 9, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next